Maternal Body Mass Index and Anovaginal Distance
AVD
1 other identifier
interventional
207
0 countries
N/A
Brief Summary
The hypothesis was that the anovaginal distance (AVD), defined as the distance between the anal mucosa and the vaginal wall at the middle level of the anal canal, is higher in obese women compared with normal weight women. Measuring the AVD with transperineal ultrasound has been shown to have a high interobserver agreement. This study aimed to establish if there was a difference in AVD measured by transperineal ultrasound between obese and normal weight women in active phase of labor at term pregnancy. The second aim was to present normal values for the AVD in active phase of labor at term pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Oct 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2016
CompletedFirst Submitted
Initial submission to the registry
May 9, 2017
CompletedFirst Posted
Study publicly available on registry
May 11, 2017
CompletedMay 16, 2017
May 1, 2017
1.5 years
May 9, 2017
May 14, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
anovaginal distance
millimeter
five minutes
Study Arms (2)
Body mass index 18.5-24.9
ACTIVE COMPARATORThe anovaginal distance was measured with transperineal ultrasound. The standardized method consisted of placing the vaginal probe at a right angle to the posterior vaginal distal wall, and in a transversal scanning plane. The internal anal sphincter was detected as a low-echogenic ring when the probe was moved cranially from the distal anal canal to the mid anal canal. The anovaginal distance was defined as the distance between the anal mucosa and the vaginal wall at the middle level of the anal.
body mass index ≥30
EXPERIMENTALThe anovaginal distance was measured with transperineal ultrasound. The standardized method consisted of placing the vaginal probe at a right angle to the posterior vaginal distal wall, and in a transversal scanning plane. The internal anal sphincter was detected as a low-echogenic ring when the probe was moved cranially from the distal anal canal to the mid anal canal. The anovaginal distance was defined as the distance between the anal mucosa and the vaginal wall at the middle level of the anal.
Interventions
transperineal ultrasound was used by placing a vaginal ultrasound probe towards the vaginal distal wall pointing to the anus, measuring the anovaginal distance.
Eligibility Criteria
You may qualify if:
- Active labor according to the Swedish definition; two out of three of the following criteria must be present: painful contractions (two to three contractions in every ten minutes), cervix shortened and dilated \> one centimeter (cm) and/or rupture of membranes.
- The maximum cervix dilatation was of seven centimeters.
- The participant had to be aged ≥18 years
- The participant had to be proficient in the Swedish language
You may not qualify if:
- Not in active labor,
- Cervix dilatation of more than seven centimeters,
- Age \<19
- Not speaking Swedish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Hjertberg L, Uustal E, Pihl S, Blomberg M. Maternal Body Mass Index and Anovaginal Distance in Active Phase of Term Labor. Biomed Res Int. 2018 Mar 7;2018:1532949. doi: 10.1155/2018/1532949. eCollection 2018.
PMID: 29707565DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie Blomberg, Assoc prof
Departement of obstetrics and gynecology, Linkopings University, Sweden
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated professor
Study Record Dates
First Submitted
May 9, 2017
First Posted
May 11, 2017
Study Start
October 2, 2014
Primary Completion
March 31, 2016
Study Completion
March 31, 2016
Last Updated
May 16, 2017
Record last verified: 2017-05
Data Sharing
- IPD Sharing
- Will not share